These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15124980)

  • 1. Influence of an antivertiginous combination preparation of cinnarizine and dimenhydrinate on event-related potentials, reaction time and psychomotor performance--a randomized, double-blind, 3-way crossover study in healthy volunteers.
    Philipova D; Tzenova B; Iwanowitsch A; Bognar-Steinberg I
    Int J Clin Pharmacol Ther; 2004 Apr; 42(4):218-31. PubMed ID: 15124980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of 3 antivertiginous medications on the vigilance of healthy volunteers.
    Schneider D; Kiessling B; Wieczorek M; Bognar-Steinberg I; Schneider L; Claussen CF
    Int J Clin Pharmacol Ther; 2003 Apr; 41(4):171-81. PubMed ID: 12708605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
    Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G
    Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cinnarizine/dimenhydrinate fixed combination with the respective monotherapies for vertigo of various origins: a randomized, double-blind, active-controlled, multicentre study.
    Hahn A; Novotný M; Shotekov PM; Cirek Z; Bognar-Steinberg I; Baumann W
    Clin Drug Investig; 2011; 31(6):371-83. PubMed ID: 21401214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.
    Scholtz AW; Steindl R; Burchardi N; Bognar-Steinberg I; Baumann W
    Clin Drug Investig; 2012 Jun; 32(6):387-99. PubMed ID: 22506537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial.
    Scholtz AW; Hahn A; Stefflova B; Medzhidieva D; Ryazantsev SV; Paschinin A; Kunelskaya N; Schumacher K; Weisshaar G
    Clin Drug Investig; 2019 Nov; 39(11):1045-1056. PubMed ID: 31571128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.
    Novotný M; Kostrica R
    Int Tinnitus J; 2002; 8(2):115-23. PubMed ID: 14763223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR; Gonen A; Nachum Z; Doweck I; Spitzer O; Shupak A
    J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study.
    Scholtz AW; Schwarz M; Baumann W; Kleinfeldt D; Scholtz HJ
    Clin Ther; 2004 Jun; 26(6):866-77. PubMed ID: 15262457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of vertebrobasilar insufficiency--associated vertigo with a fixed combination of cinnarizine and dimenhydrinate.
    Otto V; Fischer B; Schwarz M; Baumann W; Preibisch-Effenberger R
    Int Tinnitus J; 2008; 14(1):57-67. PubMed ID: 18616088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effects of anti-motion sickness drugs on vestibular evoked myogenic potentials outcome parameters.
    Vanspauwen R; Weerts A; Hendrickx M; Buytaert KI; Blaivie C; Jorens PG; Van de Heyning PH; Wuyts FL
    Otol Neurotol; 2011 Apr; 32(3):497-503. PubMed ID: 21307816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders : a randomized, reference-controlled clinical study.
    Hahn A; Sejna I; Stefflova B; Schwarz M; Baumann W
    Clin Drug Investig; 2008; 28(2):89-99. PubMed ID: 18211117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, placebo-controlled study comparing two formulations of dimenhydrinate with respect to efficacy in motion sickness and sedation.
    Seibel K; Schaffler K; Reitmeir P; Golly I
    Arzneimittelforschung; 2002; 52(7):529-36. PubMed ID: 12189776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car.
    Ridout F; Shamsi Z; Meadows R; Johnson S; Hindmarch I
    Clin Ther; 2003 May; 25(5):1518-38. PubMed ID: 12867226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Pharmacological Appropriateness of Cinnarizine and Dimenhydrinate in the Treatment of Vertigo and Related Symptoms.
    Plescia F; Salvago P; Dispenza F; Messina G; Cannizzaro E; Martines F
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33946152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of a Fixed-Dose Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg in the Treatment of Patients with Vestibular Vertigo: An Individual Patient Data Meta-Analysis of Randomised, Double-Blind, Controlled Clinical Trials.
    Scholtz AW; Waldfahrer F; Hampel R; Weisshaar G
    Clin Drug Investig; 2022 Sep; 42(9):705-720. PubMed ID: 35864302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effects of anti-motion sickness drugs on subjective sleepiness and cognitive performance of healthy males.
    Weerts AP; Pattyn N; Van de Heyning PH; Wuyts FL
    J Psychopharmacol; 2014 Jul; 28(7):655-64. PubMed ID: 24346808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of common antivertiginous agents on the high velocity vestibulo-ocular reflex.
    Anagnostou E; Koutsoudaki P; Stavropoulos A; Evdokimidis I
    Clin Neurophysiol; 2017 Nov; 128(11):2211-2216. PubMed ID: 28985517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare.
    Hindmarch I; Johnson S; Meadows R; Kirkpatrick T; Shamsi Z
    Curr Med Res Opin; 2001; 17(4):241-55. PubMed ID: 11922397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system effects of meclizine and dimenhydrinate: evidence of acute tolerance to antihistamines.
    Manning C; Scandale L; Manning EJ; Gengo FM
    J Clin Pharmacol; 1992 Nov; 32(11):996-1002. PubMed ID: 1474173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.